What is NDC 59651-601?

59651-601 is the product NDC for Deflazacort, Deflazacort 30 mg/1 tablet, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Deflazacort?

31 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Deflazacort NDC 59651-601 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)59651-601Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59651-0601Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59651-601-30	5965106013059651060130	30 TABLET in 1 BOTTLE (59651-601-30)Marketed from Feb 9, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Deflazacort
Generic name (nonproprietary): deflazacort
Active ingredients: Deflazacort — 30 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Aurobindo Pharma LimitedNDC labeler code 59651
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217123
Marketing start: Feb 9, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 59651-601_a6a915ee-9df8-46ee-a6b7-794834417917SPL ID a6a915ee-9df8-46ee-a6b7-794834417917SPL set ID 77d7525d-89c9-4fde-a6a8-0a463fd6cfebRxCUI 153098, 153880, 1870954, 1870958UNII KR5YZ6AE4BUPC 0359651600306
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459651060130 followed by a unit qualifier and the quantity

Package 59651-0601-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 1, 2026.

Indications (excerpt from the label)

Deflazacort tablets are indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older. Deflazacort is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 59651-601

What is NDC 59651-601?: 59651-601 is the product NDC for Deflazacort, Deflazacort 30 mg/1 tablet, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Deflazacort.
What is the active ingredient?: Deflazacort.
Who is the labeler?: Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Deflazacort?: 31 other product NDCs are listed under this name. See all Deflazacort NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Deflazacort NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Deflazacort	Deflazacort 6 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0824	00054-0824-25
Deflazacort	Deflazacort 18 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0825	00054-0825-13
Deflazacort	Deflazacort 30 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0826	00054-0826-13
Deflazacort	Deflazacort 36 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0827	00054-0827-13
Deflazacort	Deflazacort 6 mg/1	TabletOral	Amneal Pharmaceuticals NY LLC	60219-2282	60219-2282-01
Deflazacort	Deflazacort 18 mg/1	TabletOral	Amneal Pharmaceuticals NY LLC	60219-2283	60219-2283-01
Deflazacort	Deflazacort 30 mg/1	TabletOral	Amneal Pharmaceuticals NY LLC	60219-2284	60219-2284-01
Deflazacort	Deflazacort 36 mg/1	TabletOral	Amneal Pharmaceuticals NY LLC	60219-2285	60219-2285-01
Deflazacort	Deflazacort 6 mg/1	TabletOral	AvKARE	73190-068	73190-0068-01
Deflazacort	Deflazacort 18 mg/1	TabletOral	AvKARE	73190-069	73190-0069-30

All 32 Deflazacort NDCs

Other NDCs under ANDA 217123

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217123
Product	Strength	Form · route	Labeler	Product NDC
Deflazacort	Deflazacort 6 mg/1	TabletOral	Aurobindo Pharma Limited	59651-599
Deflazacort	Deflazacort 18 mg/1	TabletOral	Aurobindo Pharma Limited	59651-600
Deflazacort	Deflazacort 36 mg/1	TabletOral	Aurobindo Pharma Limited	59651-602